secwatch.observer — SEC 8-K summary
======================================

Issuer:     DANAHER CORP /DE/ (DHR)
CIK:        0000313616
Form:       8-K
Filed at:   2024-04-23T23:59:59+00:00
Accession:  0000313616-24-000106
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Danaher Q1 2024 beats expectations with $5.8B revenue, $1.92 adj EPS
--------------------------------------------------------------------

- Net earnings $1.1B, diluted EPS $1.45; adjusted diluted EPS $1.92.
- Revenue $5.8B, down 2.5% YoY; core revenue down 4.0%.
- Operating cash flow $1.7B; free cash flow $1.4B.
- CEO reports improving bioprocessing order trends and market share gains in molecular diagnostics at Cepheid.
- Q2 core revenue expected down mid-single digits; full year 2024 core revenue expected down low-single digits.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/313616/000031361624000106/0000313616-24-000106-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/313616/000031361624000106/dhr-20240423.htm
  HTML page:      https://secwatch.observer/filing/0000313616-24-000106

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer